As of Tuesday, December 23, Burning Rock Biotech Limited’s BNR share price has dipped by 9.53%, which has investors questioning if this is right time to buy.

Arrangements provide increased near-term funding and extend maturity of credit agreement to early 2027 - Equity settlement mechanisms also agreed for milestone payments and contingent acquisition ...

Developers of a lab-grown blood vessel designed to save life and limb in emergency scenarios appear to be promoting its use ...